Local Institution - 005-191 — Coeur d'Alene, Idaho

Local Institution - 005-191 is a clinical research site located in Coeur d'Alene, Idaho, United States 83814.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 005-191 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Squamous Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Coeur d'Alene

Browse all research sites in Idaho · View every site in Coeur d'Alene

• Northwest Specialty Hospital
• Kootenai Hospital District dba Kootenai Health
• University of Idaho
• Kootenai Health - Coeur d'Alene
• Kootenai Medical Center
• GSK Investigational Site
• Research Site
• North Idaho Urology
• North Idaho Cancer Center
• Coeur D'Alene Arthritis Clinic
• Kootenai Health
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 005-191?

Local Institution - 005-191 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 005-191 conducted?

Local Institution - 005-191 has 1 clinical trials on record. Their work covers Metastatic Non-Squamous Non-Small Cell Lung Cancer.

Is Local Institution - 005-191 accredited by Crixeo Clinical Trials?

Local Institution - 005-191 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 005-191?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.